[1]
A. Kumari, R. Rohatgi, A. Singh, and R. Kumar, “Comparative study of intravenous hydralazine and labetalol in severe hypertensive disorders of pregnancy”, Int J Reprod Contracept Obstet Gynecol, vol. 9, no. 2, pp. 675–681, Jan. 2020.